For Debate Parasitic Infection and Autoimmunity

References

• Isenberg D A, Shoenfeld Y, Walport M, Mackworth‐Young C, Dudeney C, Toddopokpopet A. Detection of cross reactive anti‐DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and their relatives. Arthritis Rheum. 1985; 28: 999–1007
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Segol G, Segol O, Klajman A, Stollar B D, Isenberg D A. Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum. 1987; 30: 169–175
   PubMedGoogle Scholar
• Shoenfeld Y, Ben‐Yehuda O, Naparstek Y, Pick A I. The detection of a common idiotype of anti‐DNA in the sera of patients with monoclonal gammopathies. J Clin Immunol. 1986; 6: 194–204
   PubMed Web of Science ®Google Scholar
• Abu‐Shakra M, Krupp M, Argov S, Buskila D, Slor H, Shoenfeld Y. The detection of anti‐Sm‐RNP activity in sera of patients with monoclonal gammopathies. Clin Exp Immunol. 1989; 75: 349–353
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Schwartz R S. Immunologic and genetic factors in autoimmune diseases. New Eng J Med. 1984; 311: 1019–1029
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Isenberg D A. The Mosaic of Autoimmunity Factors associated with autoimmunity. Elsevier, Amsterdam 1989; 1–600
   Google Scholar
• Abu‐Shakra M, Shoenfeld Y. The Gm allotypes and autoimmune diseases. Immunol Res. 1989; 8: 281–291
   PubMedGoogle Scholar
• Shoenfeld Y, Isenbere D A. The mosaic of autoimmunity. Immunology Today. 1989; 10: 123–126
   PubMedGoogle Scholar
• Dawkins R L, Garlepp M J, McDonald B L. Myasthenia gravis and D‐penicillamine. J Rheumatol. 1981; 7: 169–172
   Google Scholar
• Shoenfeld Y, Cohen I R. Infection and autoimmunity. The Antigens, M Sela. Academic Press. 1987; Vol 7: 307–325
   Google Scholar
• Greenwood B M, Muller A S, Valkenburg H A. Rheumatoid factor in Nigerian sera. Clin Exp Immunol. 1971; 8: 161–173
   Google Scholar
• Voller A, O'Neill P, Humphrey D. Serological studies in Tanzania. I. I. Antinuclear factor and malarial antibodies in population living at different altitudes. J Trop Med Hyg. 1972; 75: 136–139
   PubMedGoogle Scholar
• Boonpucknavig S, Ekapanyakuld G. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection. Clin Exp Immunol. 1984; 58: 77–82
   PubMedGoogle Scholar
• Sharper A G, Kaplan M H, Mody N J, McIntyre P A. Malaria antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous people of Uganda. Lancet. 1968; i: 1342–1343
   Google Scholar
• Wells R A, Pavanand K, Zolyomi S, Permpanich B, MacDermott R B. Anti‐lymphocytotoxic antibodies in sera of Thai adults infected with plasmodium falciparum or plasmodium vivax. Clin Exp Immunol. 1980; 39: 663–667
   PubMed Web of Science ®Google Scholar
• Rosenberg E B, Strickland G T, Sen‐Lain Y, Whalen G E. IgM antibodies to red cells and autoimmune anaemia in patients with malaria. Am J Trop Med Hyg. 1973; 22: 146–150
   PubMed Web of Science ®Google Scholar
• Zouali M, Druilhe P, Equem A. IgG subclass expression of anti‐DNA and anti‐ribonucleoprotein autoantibodies in human malaria. Clin Exp Immunol. 1986; 66: 273–278
   PubMedGoogle Scholar
• Phanuphak P, Tirwatpong S, Hanvanich M, Panmuong W, Moollar P, Vejjajiva S. Autoantibodies in falciparum malari a sequential study in 183 Thai patients. Clin Exp Immunol. 1983; 53: 627–633
   PubMed Web of Science ®Google Scholar
• Adu D, Williams D G, Quakyi I A, Voller A, Anim‐Addo Y, Bruce‐Tagoe A A. Anti‐ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol. 1982; 49: 310–316
   PubMedGoogle Scholar
• Boonpucknavig V, Sitprija V. Renal disease in acute. Plasmodium falciparum infection in man. Kidney Int. 1979; 16: 44–52
   PubMed Web of Science ®Google Scholar
• Wozencraft A O, Lloyd C M, Staines N A. Role of DNA binding antibodies in kidney pathology associated with murine malaria infectious. Infec. Immun. 1990; 58: 2156–2164
   PubMedGoogle Scholar
• Mendlovic S, Brocke S, Shoenfeld Y, Ben‐Bassat M, Meshorer A, Bakimer R, Mozes E. Induction of systemic lupus erythematosus‐like syyndrome in mice by a common human anti‐DNA idiotype. Proc Nail Acad Sci. 1988; 85: 2260–2264
   PubMed Web of Science ®Google Scholar
• Thomas M A, Frampton G, Isenberg D A, Shoenfeld Y, Akinsola A, Ramsay M. A common anti‐DNA antibody idiotype and anti‐phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmunity. 1990; 2: 803–812
   Google Scholar
• Marsden P D. Selective primary health care: strategies for controls of disease in the developing world. XIV. Leishmaniasis. Rev Infect Dis. 1984; 6: 736–744
   PubMedGoogle Scholar
• Rezai H R, Ardehali S M, Amirhakimi G, Kharazmi A. Immuno‐logical features of kala‐azar. Am J Trop Hyg. 1987; 37: 1079–1083
   Google Scholar
• Pearson R D. The immunobiology of leishmaniasis. Rev Inject Dis. 1983; 907–927
   PubMedGoogle Scholar
• Carvalho E M, Andrews B S, Martinelli R, Dutra M, Rocha M. Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg. 1983; 32: 61–68
   PubMed Web of Science ®Google Scholar
• Desjeux P, Santoro F, Afchain D, Lovens D, Capron A. Circulating immune complexes and anti‐IgG antibodies in mucocutaneous leishmaniasis. Am J Trop Med Hyg. 1980; 29: 195–198
   PubMed Web of Science ®Google Scholar
• Howard M K, Miles M A. Anti‐tubulin antibodies in visceral leishmaniasis. Trans Roy Soc Trop Med Hyg. 1986; 80: 493–494
   PubMedGoogle Scholar
• Argov S, Jaffe C L, Krupp M, Slor H, Shoenfeld Y. Autoantibodies production by patients infected with leishmaniasis. Clin Exp Immunol. 1989; 76: 561–568
   Google Scholar
• Galvao‐Castro B, Sa'Ferreira J A, Marzochi K F, Marzochi M C, Coutinho S G, Lambert P H. Polyclonal B‐cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin Exp Immunol. 1984; 56: 58–66
   PubMed Web of Science ®Google Scholar
• Desjeux P, Santoro F, Afchin D, Loyens M, Capron A. Circulating immune complexes and anti‐lgG antibodies in mucocutaneous leishmaniasis. Am J Trop Med Hyg. 1980; 29: 159–98
   Google Scholar
• Pugin P, Miescher P A, Le Kala‐azar. Etude clinique et physiopathologique a propos d'un nouveau cas observe en Suisse. Schweiz Med Wochenschr. 1982; 109: 265–269
   Google Scholar
• Batto T, Hoshino‐Shimizu S, Amato‐Neto V, Duarte I S, Penna D O. Glomerular involvement in human Kala‐Azar. A light, immunofluorescent and electron microscopic study based on kidney biopsies. Am J Trop Med Hyg. 1975; 24: 9–16
   PubMedGoogle Scholar
• Lambert P H, Houba V. Immune complexes in parasitic disease. Prog Immunol. 1974; 5: 57–63
   Google Scholar
• Casali P, Lambert P H. Purification of soluble immune complexes from serum using polymethylmetacrilate beads coated with conglutinin of C1q. Clin Exp Immunol. 1979; 37: 295–309
   PubMed Web of Science ®Google Scholar
• Ramso‐Niembro F, FouriniÍ G, Lambert P H. Induction of circulating immune complexes and their renal localization acute or chronic polyclonal B‐cell activation in mice. Kidney Int. 1982; 21: S29–S38
   Google Scholar
• Rose L, Goldman M, Lambert P H. Simultaneous induction of immune complexes during African trypanosomiasis in mice. J Immunol. 1982; 28: 79–85
   Google Scholar
• Campos A R. Human schistosomiasis: schistosoma mansoni antigen detection in renal glomeruli. Trans R Soc Trop Med Hyg. 1976; 70: 492–496
   PubMedGoogle Scholar
• Lawley T J, Ottesen E A, Hiatt R A, Gazze L A. Circulating immune complexes in acute schistosomiasis. Clin Exp Immunol. 1979; 37: 221–227
   PubMedGoogle Scholar
• Border W A. Immune complex detection in glomerular diseases. Nephron. 1979; 24: 105–113
   PubMedGoogle Scholar
• Fischer E, Camus D, Santoro F, Capron A. Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice. Clin Exp Immunol. 1981; 46: 89–97
   PubMedGoogle Scholar
• Al Abdel H, El Atribi A, Hafiz A, Aidaros M. Azoospermia in bilharziasis and the presence of sperm antibodies. J Reprod Fertil. 1975; 42: 403–410
   PubMedGoogle Scholar
• Wyler D J, Lammie P J, Michael A I, Rosenwasser L J, Philips S M. In vitro and in vivo evidence that autoimmune reactivity to collagen develops spontaneously in schistosoma mansoni‐infected mice. Clin Immunol Immunopath. 1987; 44: 140–148
   PubMedGoogle Scholar
• Carson D A, Bayer A S, Eisenberg R A, Lawrece S, Theofilopouloh A N. IgG rheumatoid factor in subacute bacterial endocarditis: Relationship to IgM rheumatoid factor and circulating immune complexes. Clin Exp Immunol. 1978; 31: 100–103
   PubMed Web of Science ®Google Scholar
• Solinger A M, Bhatnagar R S, Stobo J D. Cellular, molecular and genetic characteristics of T cell reactivity to collagen in man. Proc Natl Acad Sci. 1981; 78: 3877–3881
   PubMedGoogle Scholar
• Stuart J M, Postethwaite A E, Kang A H. Evidence for cell‐mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med. 1976; 88: 601–607
   PubMedGoogle Scholar
• Kravis T C, Ahmed A, Brown T E, Fulmer J D, Crystal R E. Pathogenic mechanisms in pulmonary fibrosis: Collagen induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest. 1976; 58: 1223–1232
   PubMed Web of Science ®Google Scholar
• Foidart J N, Shizeto A, Martin G R, Zizic T M, Barnett E V, Lawley T J. Antibody to type II collagen in relapsing polychondritis. New Engl J Med. 1978; 299: 1203–1207
   PubMed Web of Science ®Google Scholar
• Stuart J M, Townes A S, Kang A H. Nature and specificity of the immune response in type II collagen induced arthritis in mice. J Clin Invest. 1982; 69: 673–683
   PubMed Web of Science ®Google Scholar
• Johnson R L, Ziff M. Lymphokine stimulation of collagen accumulation. J Clin Invest. 1976; 58: 240–252
   PubMed Web of Science ®Google Scholar
• Santo Bush C A. American trypanosomiasis: Chagas' disease. Int Rev Exp Pathol. 1979; 9: 63–95
   Google Scholar
• Anselmi A, Moleiro F. Pathogenic mechanisms in Chagas' cardiomyopathy. Ciba Found Symp. 1974; 20: 125–136
   Google Scholar
• Takle G B, Hudson L. Autoimmunity and Chagas' disease. Curr Top in Microbiol Immunol. 1989; 145: 79–92
   PubMedGoogle Scholar
• Laguens R P, Meckert P C, Chambo J G. Antiheart antibody dependent cytotoxicity in the sera of mice chronically infected with T. cruzi. Infect Immun. 1988; 56: 993–997
   PubMedGoogle Scholar
• Ben‐Nun A, Weckerle H, Cohen I R. Vaccination against autoimmune encephalomyelitis with T‐lymphocyte line cells reactive against myelin basic protein. Nature 1981; 242: 60–61
   Google Scholar
• Cossio P M, Diez C, Szarfman A. Chagasic cardiomyopathy: Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation. 1974; 49: 13–21
   PubMedGoogle Scholar
• Ribiero‐dos‐Santo R, Marquez J O, Von‐Gal‐Furtado C C. Antibodies against neurons in chronic Chagas' disease. Tropenmed Parasitol. 1979; 30: 19–23
   PubMedGoogle Scholar
• Khoury E L, Ritacco V, Cossio P M. Circulating antibodies to peripheral nerve in Chagas' disease. Clin Exp Immunol. 1979; 36: 8–15
   PubMedGoogle Scholar
• Szarfman A, Terranova V P, Rennard S I. Antibodies to laminin in Chagas' disease. J Exp Med. 1982; 155: 1161–1171
   PubMed Web of Science ®Google Scholar
• Cossio P M, Laguens R P, Kreutzer E. Chagasic cardiomyopathy: antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation. 1974; 50: 1252–1263
   PubMedGoogle Scholar
• Taylor H R. Onchocerciasis. Clinical Ophthalmology. 1984; 1–12
   Google Scholar
• Donnelly J J, Rockey J H, Bianco A E, Soulsby E J L. Ocular immunopathologic findings of experimental onchocerciasis. Arch Ophthalmol. 1984; 102–628
   Google Scholar
• Sakla A A, Donnelly J J, Lok J B, Khatami M, Rockey J H. Punctate keratitis induced by subconjunctival injection of guinea pigs with onchocerca lienalis microfilariae. Arch Ophthalmol. 1986; 104: 894
   PubMedGoogle Scholar
• Liu S H. Experimental model of autoimmune keratitis. Invest Ophthalmol Vis Sci. 1983; 24: 100, (Suppl)
   Google Scholar
• Donnelly J J, Mu‐Shi Xi, Dolores J P, et al. Autoantibody induced by experimental Onchocera infection. Invest Ophthalmol Vis Sci. 1988; 29: 827–831
   PubMedGoogle Scholar
• Chan C C, Nussenblatt R B, Kim M K, et al. Immunopathology of ocular onchocerciasis. 2. Anti‐retina autoantibodies in serum and ocular fluids. Ophthalmology. 1987; 94: 439–443
   PubMed Web of Science ®Google Scholar
• Howard M K, Gull K, Miler M A. Antibodies to tubulin in patients with parasitic infections. Clin Exp Immunol. 1987; 68: 78–85
   PubMedGoogle Scholar
• Damian R. Molecular Mimicry: Parasite evastion and host defence. Current Topics in Microbiology and Immunology. Springer‐Verlag, Heidelberg 1989; Vol 145: 101–115
   Google Scholar
• McCauliffe D P, Zappi E, Lieu T S, Michalak M. A human Ro/SS‐A autoantigen is the homologue of calreticulin and is highly homologous with Onchocercal RAL‐1 antigen and an Aplysia “Memory Molecule”. J Clin Invest. 1990; 86: 332–335
   PubMedGoogle Scholar
• Cheung A, Leban J, Shaw A R, Merkli B, Stocker J, Chizzloini C. Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozite antibodies. Proc Natl Acad Sci. 1986; 83: 8328–8332
   PubMed Web of Science ®Google Scholar
• Dame J B, Williams J L, McCutchan T F, Weber J L, Wirtz R A, Hockmeyer W T. Structure of the gene encoding the immuno‐dominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 1984; 225: 593–599
   PubMed Web of Science ®Google Scholar
• Dixit V M, Hennessy S W, Grant G A, Rotwein P, Frazier W A. Characterization of cDNA encoding the heparin and collagen binding domains of human thromboplastin. Proc Natl Acad Sci. 1986; 83: 5449–5453
   PubMed Web of Science ®Google Scholar
• Bianco A E, Favaloro J M, Burkot T R. A repetitive antigen of plasmodium falciparum that is homologous to heat shock protein 70 of Drosophila melanogaster. Proc Natl Acad Sci. 1986; 83: 8713–8717
   PubMedGoogle Scholar
• Yuckenberg P D, Poupin F, Mansour F. Schistosoma mansoni: protein composition and synthesis during early development; evidence for early synthesis of heat shock proteins. Exp Parasitol. 1987; 63: 301–311
   PubMedGoogle Scholar
• Minota S, Koyasu S, Yahara I. Autoantibodies to the heat shock protein in systemic lupus erythematosus. J Clin Invest. 1988; 81: 106–109
   PubMedGoogle Scholar
• Norton P M, Isenberg D A, Lachman D S. Elevated levels of the 90 kd heat shock proteins with active disease. J Autoimmunity. 1989; 2: 187–195
   PubMed Web of Science ®Google Scholar
• Meeting report: International meeting on the association between rheumatoid arthritis and mycobacterial infection. Autoimmunity. 1988; 2: 73–76
   PubMedGoogle Scholar
• Dragon E A, Sias S R, Kato E A. The genome of Trypanosoma cruzi contains a constitutively expressed, randomly arranged multicopy gene homologous to a major heat shock protein. Mol cel biology. 1987; 7: 1271–1275
   PubMedGoogle Scholar
• Anders R F, Shi P T, Scanlon D B, Leach S J, Coppel R L, Brown G V. Antigenic repeat structure in proteins of plasmodium falciparum. Synthetic peptides as antigen. Ciba Foundation Symposium. Wiley, Chichester, 986, 119, 164–178
   Google Scholar
• Rosenberg Y J. Autoimmune and polyclonal B‐cell responses during malaria. Nature 1987; 274: 170–172
   Google Scholar
• Poels L G, Van Niekerk C C, Van Der Sterrenreti C, Jerusalem C. Plasmodium berghei T‐cell dependent autoimmunity. Exp Parasitol. 1980; 49: 97–105
   PubMedGoogle Scholar
• Greenwood B M, Vick R M. Evidence for a malaria mitogen in human malaria. Nature 1975; 257: 592–594
   PubMed Web of Science ®Google Scholar
• Jeme N K. Toward a network theory of the immune system. Ann Immunol. 1974; 125: 373–377
   Google Scholar